Teva Appeals Pfizer’s Win in Detrol Patent Infringement Suit

Teva Pharmaceuticals USA Inc.and it subsidiary Ivax Pharmaceuticals Inc. filed a notice of appeal last Wednesday in the U.S. District Court for the District of New Jersey, to appeal its loss to Pfizer Inc. of a patent infringement suit over Detrol. Teva is appealing the federal court’s ruling of last Tuesday that they had failed to show Pfizer’s patent for the bladder control drug was invalid and not enforceable.



Categories: infringement, News, Patents, pharmaceuticals, pharmaceuticals and Biotechnology, Teva, US

Leave a Reply

Fill in your details below or click an icon to log in:

WordPress.com Logo

You are commenting using your WordPress.com account. Log Out /  Change )

Google photo

You are commenting using your Google account. Log Out /  Change )

Twitter picture

You are commenting using your Twitter account. Log Out /  Change )

Facebook photo

You are commenting using your Facebook account. Log Out /  Change )

Connecting to %s

%d bloggers like this: